Cart
sales@molnova.com
SU-909
CAS No. 2126749-48-0
SU-909( SU909 | SU 909 | IKKα-IN-48 )
Catalog No. M13383 CAS No. 2126749-48-0
SU-909 (SU909, IKKα-IN-48) is a potent, selective IKKα inhibitor with Ki of 0.08±0.07 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSU-909
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU-909 (SU909, IKKα-IN-48) is a potent, selective IKKα inhibitor with Ki of 0.08±0.07 uM.
-
DescriptionSU-909 (SU909, IKKα-IN-48) is a potent, selective IKKα inhibitor with Ki of 0.08±0.07 uM, 10-20-fold selectivity over IKKβ (IC50=1.0±0.28 uM); inhibits FCS-stimulated phosphorylation of p100 in U2OS cells with IC50 of 8.8 uM, inhibits the noncanonical NF-kB pathway without affecting IKKβ-dependent IKappa-Bα loss in the canonical pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsSU909 | SU 909 | IKKα-IN-48
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorIκB kinase (IKK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2126749-48-0
-
Formula Weight314.323
-
Molecular FormulaC13H10N6O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name4-(2-Amino-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-4-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Anthony NG, et al. J Med Chem. 2017 Aug 24;60(16):7043-7066.
molnova catalog
related products
-
HPN-01
HPN-01 (IKK inhibitor XII) is a selective IKK inhibitor that inhibits IKK-α, IKK-β, and IKK-ε. HPN-01 reduces the severity of the disease, attenuates the immune imbalance, and prolongs the lifespan of mice in a model of autoimmune encephalomyelitis, and can be used to study immune disorders.
-
GSK319347A
GSK319347A is a selective and potent dual inhibitor of TBK1 and IKKε with potential anti-tumor activity and inhibition of IKK2 activity, which can be used in the study of bladder cancer and lung adenocarcinoma.
-
BMS-345541 free base
A potent and selective IKK-2 inhibitor with IC50 of 0.3 uM.
